Offer - Urjas Oil for just ₹ 1 X
Vigoquin T is an allopathic medicine The correct dosage of Vigoquin T depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Vigoquin T is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Vigoquin T safe for pregnant women?
Vigoquin T shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Vigoquin T safe during breastfeeding?
Vigoquin T can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Vigoquin T on the Kidneys?
Vigoquin T may have mild side effects on the kidneys.
What is the effect of Vigoquin T on the Liver?
Vigoquin T is completely safe for the liver.
What is the effect of Vigoquin T on the Heart?
You can take Vigoquin T without any fear of damage to the heart.
Vigoquin T should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Vigoquin T unless your doctor advises you to do so -
Is this Vigoquin T habit forming or addictive?
No, you will not get addicted to Vigoquin T.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Vigoquin T since it will not make you feel sleepy.
Is it safe?
Vigoquin T should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Vigoquin T cannot treat any kind of mental disorder.
Interaction between Food and Vigoquin T
Taking Vigoquin T with food does not harm your health.
Interaction between Alcohol and Vigoquin T
It is difficult to say anything about the effect of Vigoquin T and alcohol. No research has been done on this yet.
Yes, Vigoquin T is helpful in treating pneumonia. It is used in the treatment of commnunity acquired pneumonia caused by bacteria Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, and Chlamydophilia pneumoniae. The duration of treatment depends on infection severity and patients medical condition but it is generally given for 7-14 days.
No, Vigoquin T does not cause weight gain. It has not been reported by the patients who are taking. However, if notice any unusual weight gain after taking this drug and you are in doubt that Vigoquin T is causing weight gain then discuss it with your doctor.
Vigoquin T is a brand name of moxifloxacin and it comes in form of a tablet, infusion, eye drops, and eye ointment. It is a prescription drug that belongs to the class of drug known as fluoroquinolones. It is a broad spectrum antibiotic which is used for the treatment of bacterial infections such as skin infections, eye infections, intra-abdominal infections, chronic bronchitis, community-acquired pneumonia, and sinusitis.
No, Vigoquin T does not cover strains of Pseudomonas aeruginosa. It is generally found to be resistant to Vigoquin T. Hence other antibiotics which are active against Pseudomonas aeruginosa should be used.
Yes, Vigoquin T can treat strep. It is used in the treatment of strep throat (pharyngitis) caused by Group A Streptococcus bacteria such as Streptococcus pyogenes. However, it is not generally preferred as a first line drug of choice for the treatment of strep throat.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tobramycin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-141